Diego A. Díaz García, Medical Oncologist, Fellow in Thoracic Oncology at National Cancer Institute of Mexico, shared on X:
“HER2 testing is evolving fast.
•The evolution of HER2 testing methodologies.
•Current guidelines across tumor types.
•Challenges with IHC and FISH in HER2-low settings.
•The promise of quantitative and RNA-based assays.”
Title: HER2 testing: evolution and update for a companion diagnostic assay
Authors: Charles J. Robbins, Katherine M. Bates and David L. Rimm
Find More Posts Featuring HER2 testing on OncoDaily
